Donate now

Harriet Rumgay Epidemiologist
Cancer Surveillance

Speciality: Descriptive cancer epidemiology
Year Degree Major Institution Country/Town
2022 PhD Cancer Epidemiology Erasmus University Rotterdam Netherlands / Rotterdam
2014 BSc Biology Imperial College London UK / London
Current Research Projects

Cancer burden attributable to tobacco and alcohol


Avoidable cancers


Selected Publications

Rumgay H, Arnold M, Ferlay J, Lesi O, Cabasag CJ, Vignat J, Laversanne M, McGlynn KA, Soerjomataram I. Global burden of primary liver cancer in 2020 and predictions to 2040. J Hepatol. 2022 Dec;77(6):1598-1606. doi: 10.1016/j.jhep.2022.08.021

Rumgay H, Ferlay J, de Martel C, Georges D, Ibrahim AS, Zheng R, Wei W, Lemmens VEPP, Soerjomataram I. Global, regional and national burden of primary liver cancer by subtype. Eur J Cancer. 2022 Jan;161:108-118. doi: 10.1016/j.ejca.2021.11.023

Rumgay H, Shield K, Charvat H, Ferrari P, Sornpaisarn B, Obot I, Islami F, Lemmens VEPP, Rehm J, Soerjomataram I. Global burden of cancer in 2020 attributable to alcohol consumption: a population-based study. Lancet Oncol. 2021 Aug;22(8):1071-1080. doi: 10.1016/S1470-2045(21)00279-5

Rumgay H, Arnold M, Laversanne M, Whiteman DC, Thrift AP, Wei W, Lemmens VEPP, Soerjomataram I. International Trends in Esophageal Squamous Cell Carcinoma and Adenocarcinoma Incidence. Am J Gastroenterol. 2021 May 1;116(5):1072-1076. doi: 10.14309/ajg.0000000000001121

Brown KF, Rumgay H, Dunlop C, Ryan M, Quartly F, Cox A, Deas A, Elliss-Brookes L, Gavin A, Hounsome L, Huws D, Ormiston-Smith N, Shelton J, White C, Parkin DM. The fraction of cancer attributable to modifiable risk factors in England, Wales, Scotland, Northern Ireland, and the United Kingdom in 2015. Br J Cancer. 2018 Apr;118(8):1130-1141. doi: 10.1038/s41416-018-0029-6

Close Reading Mode
Publication status

Published in section: WHO'S WHO

Publication date: 25 February, 2019, 10:50

Direct link: https://d2u7e27yy6nebm.cloudfront.net/staff_member/harriet-rumgay/

© Copyright International Agency on Research for Cancer 2024